Other Industry News

Tencent Leads $200 Million Round in Haodaifu, a Mobile Healthcare App

Tencent Holdings, China's largest internet services company, led a $200 million series D round in Haodaifu Online, a large mobile healthcare app. Founded in 2006, Haodaifu, which translates into &quo... Full Story

CohBar, Inc.’s CEO Simon Allen to Present at the 1st Annual H.C. Wainwright & Co. NASH Investor Conference in New York

, a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today that its CEO Simon Allen will present an overview ... Full Story

JHL Starts European Trial of MabThera/RituxanBiosimilar for RA

JHL Biotech has dosed the first patient in a European trial of JHL1101, a biosimilar to the Roche/Genentech rheumatoid arthritis treatment MabThera/Rituxan. JHL is a Taiwan-China biotech, formed by Genen... Full Story

Naturally Splendid to Appear in the Canadian Cannabis Investor Magazine and on the U.S. Cannabis Investor Webcast

is pleased to announce that it will be featured in the inaugural April issue of the new Canadian CANNAINVESTOR Magazine. To view the Company’s feature article in the new Canadian CANNAINVESTOR Magazine... Full Story

RepliCel's Successful RCT-01 Tendon Repair Clinical Trial Shows Signs of Healing Chronic Tendon Problems

 ("RepliCel" or the "Company") is pleased to report compelling safety and clinical data from its phase 1/2 tendon repair study investigating the use of RepliCel's type 1 collagen... Full Story

DelMar Pharmaceuticals Announces Abstract Presentations for the American Association for Cancer Research (AACR) Annual Meeting in April 2017

, a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it will present three abstracts at the American Association of Cancer Researc... Full Story

Gene Quantum (Suzhou) Raises $5.8 Million in A Round for ADC Drugs

GeneQuantum Healthcare of Suzhou raised $5.8 million to advance its development of novel antibody drug conjugates toward IND filings. Founded in 2013, GeneQuantum says its proprietary next-generation Lig... Full Story

Chinese drug approval boosts AstraZeneca's lung cancer hopes

AstraZeneca has won approval for its lung cancer pill Tagrisso in China, a key market for the potential blockbuster medicine. Tagrisso is designed to help cancer patients with certain genetic mutation... Full Story

TaiGen Sells 9% of China JV to HEC ChangJiang for $20 Million

South Korea's TaiGen Biotech will be paid $20 million for a 9% interest in a China JV by its partner YiChang HEC ChangJiangPharma. The JV, formed six months ago, is developing two direct acting anti-... Full Story

WuXiAppTec Plans China IPO

Wuxi AppTec, China's largest CRO/CMO, has begun the application process for an IPO on a China exchange. Previously, the company was rumored to favor a reverse-merger transaction, which is generally c... Full Story


Company Search

Upcoming Events More

APR
22
SAT

GCFF Vancouver Conference 2017 - Discovering Alternative Investments in Innovation

Over the years, investors have seen how exciting opportunities in innovation have matured into solid investments. Advances in AI, Big Data, Clean Technology and Health Care have all led ... Event Info